Morse Asset Management’s Gilead Sciences GILD Stock Holding History

Morse Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171K	Sell	1,354 -2,275	-63%	-$300K	0.03%	169
2026 Q1	$506K	Sell	3,629 -6,271	-63%	-$878K	0.11%	125
2025 Q4	$1.22M	Buy	+9,900	New	+$1.2M	0.24%	81
2019 Q3	–	Sell	-17,655	Closed	-$1.19M	–	130
2019 Q2	$1.19M	Sell	17,655 -18,520	-51%	-$1.22M	0.35%	69
2019 Q1	$2.35M	Sell	36,175 -11,450	-24%	-$761K	0.71%	42
2018 Q4	$2.98M	Sell	47,625 -1,860	-4%	-$130K	1.06%	30
2018 Q3	$3.82M	Buy	49,485 +4,950	+11%	+$374K	1.01%	29
2018 Q2	$3.15M	Sell	44,535 -7,585	-15%	-$536K	0.86%	36
2018 Q1	$3.93M	Buy	52,120 +10,940	+27%	+$870K	1.09%	29
2017 Q4	$2.95M	Buy	41,180 +2,080	+5%	+$158K	0.82%	40
2017 Q3	$3.17M	Buy	39,100 +13,340	+52%	+$1.02M	0.94%	35
2017 Q2	$1.82M	Sell	25,760 -5,850	-19%	-$389K	0.59%	57
2017 Q1	$2.15M	Buy	+31,610	New	+$2.22M	0.73%	47

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Morse Asset Management's GILD Position: Q2 2026 in Review

Morse Asset Management reduced its Gilead Sciences (GILD) stake by 63% in Q2 2026, selling an estimated $300K and leaving 1,354 shares worth $171K. The position accounts for 0.03% of the portfolio, ranked #169.

Morse Asset Management first reported a position in GILD in Q1 2017 and has held it in 13 quarters since. The position peaked at $3.93M in Q1 2018. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Morse Asset Management held 1,354 shares of Gilead Sciences worth $171K as of Q2 2026.
Morse Asset Management sold 2,275 Gilead Sciences shares in Q2 2026, an estimated $300K.
Gilead Sciences made up 0.03% of Morse Asset Management's portfolio in Q2 2026, its #169 holding.
Morse Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 13 quarters since.
Morse Asset Management's Gilead Sciences position peaked at $3.93M in Q1 2018.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.